Check 35,000+ stocks against 26 valuation models and 37 quality factors

Streamline Health Solutions Inc (STRM) fair value: what the stock is really worth

We calculate from audited financials what Streamline Health Solutions Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Sep 13, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.

Fair value above price? No
Good quality? No
Add to watchlist

Healthcare · US · ISIN US86323X1063

Thin data Sep 13, 2026

Streamline Health Solutions Inc

STRM · US

Low PriorityFair Value upside is limited and quality is weak.

·Fair value $0.6700 · Fairly valued (−1.5%)

!Quality 24/100

!Weak Growth (revenue 5y −2.9 %/yr)

!Loss-making · -49.3% net margin (TTM)

!Moderate debt · negative free cash flow

!Trails peers (1/8)

!Narrow moat 8/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear $0.6200 to bull $0.7300 Growth analysisrevenue history, year by year Quality 24/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Streamline Health Solutions Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range $0.1800 – $34.05 · fair‑value band $0.6200 – $0.7300 · the $0.6800 price screens above the $0.6700 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.

Follow Streamline Health Solutions in your weekly email

Every Wednesday you see whether Streamline Health Solutions is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in North America.

Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID Automated Revenue Reconciliation, a cloud-based SaaS solution that delivers automated, daily charge reconciliation that identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and billed; eValuator Coding Analysis Platform, a cloud-based SaaS solution that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team; Data Comparison Engine, a cloud-based SaaS system synchronization module that reconciles data in different software used by hospitals within their operations; Coding & CDI Solutions, provides an on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables sharing of patient data; and Financial Management Solutions that enable financial staff across the healthcare enterprise to drill down into actionable and real-time financial data and key performance indicators. It also provides technology-enabled audit and coding services; software services, including data collection, configuration of the software based on the clients' needs, training, and support services; and professional services. The company sells its solutions and services through direct sales force or through third-party resellers. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Stock analysis

Streamline Health Solutions Inc (STRM) currently trades at $0.6800, while our model-based Fair Value estimate is $0.6700, so the stock looks roughly fairly valued today (gap 1.5%).

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.6200 (bear) to $0.7300 (bull), the price of $0.6800 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 24/100 (below-average quality), in the Healthcare sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Streamline Health Solutions Inc reported revenue of $17.9M in FY2025 versus $11.3M in FY2021, a compound +12.1%/yr. Reported net income was −$10.2M in FY2025.

Key figures

Market cap $23.2M · P/S ratio 1.26 · EPS (TTM) $−2.22 · Net margin −56.8% · Return on equity −63.9% · Return on assets (EBIT) −25.4% · Operating margin −71.4% · Revenue (TTM) $18.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 278% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −1%, STRM screens richer than that median.

Fair Value models

Bear $0.6200 Fair Value $0.6700 Bull $0.7300

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

NCAV (Graham) $0.1100 $0.1500 $0.2200 54

All 1 models by family

Asset-Based

NCAV (Graham) $0.1100 $0.1500 $0.2200 54

Open the full fair value analysis →

Notify me when STRM reaches fair value

Put STRM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 24/100

Of which business quality 24 · Market factors (momentum, volatility) 31

Profitability 15

Margins and returns on capital today

Quality Growth 47

Are margins and returns improving?

Cashflow 0

Earnings quality: real cash, not paper profit

Fin. Strength 19

Balance sheet, leverage, solvency risk

Investment 95

Disciplined investing over empire-building

Low Volatility 0

Calm price path (market factor)

Momentum 67

Price trend over the last 3–12 months (market factor)

52W Momentum 5

Distance to the 52-week high (market factor)

Net Issuance 0

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100

Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Revenue growth 1 year

−20.8%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−2.9%

Start year 2020 (pandemic). Over 10 years: −4.2% a year

Revenue growth 29 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+4.5%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−7.3% (2020) → −44.9% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

Watch STRM, get fair value alerts →

Compare Streamline Health Solutions Inc with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 128 stocks

Beats the industry median on 0/6 measures

Overall it trails its industry peers.

Valuation

Quality Score 24 · Bottom 25%

Profitability

Return on assets −11.1% · Bottom 25%

Net margin (TTM) −49.3% · Bottom 25%

Operating margin (TTM) −71.4% · Bottom 25%

Growth and dividend

Revenue growth −0.7% · Below median

Balance sheet

Debt / equity 0.74× · Highest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)31 · sector 0

FUTURE (revenue growth)0 · sector 41

PAST (return on equity)0 · sector 8

HEALTH (low debt)63 · sector 98

DIVIDEND (yield)0 · sector 44

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Veeva Systems Inc VEEV	$278.57	$306.43	+10%
Pro Medicus Limited PME	A$161.00	A$84.62	−47%
BrightSpring Health Services, Inc BTSG	$56.54	$25.86	−54%
Hinge Health, Inc HNGE	$95.57	$51.25	−46%
HealthEquity, Inc HQY	$88.44	$97.28	+10%
Waystar Holding WAY	$24.70	$27.17	+10%
Doximity, Inc DOCS	$26.35	$31.41	+19%
XtalPi Holdings 2228	HK$7.75	HK$1.50	−81%
Inventurus Knowledge Solutions Limited IKS	₹1,779	₹1,883	+6%
Privia Health Group PRVA	$19.62	$5.02	−74%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Streamline Health Solutions Inc · Fair Value
$0.6700 −1%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/STRM" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Streamline Health Solutions Inc · Fair Value</span><br><b style="font-size:20px">$0.6700</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−1%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Streamline Health Solutions Inc Fair Value". https://www.fairvalue-calculator.com/stock/STRM

Frequently asked questions

Is Streamline Health Solutions Inc (STRM) overvalued or undervalued?

As of Sep 13, 2026, our model estimates a fair value of $0.6700 versus a price of $0.6800, about −1% upside (fairly valued).

What is the fair value of STRM?

Our model-based fair value for Streamline Health Solutions Inc is $0.6700 (as of Sep 13, 2026), built from audited fundamentals. The current price: $0.6800.

What is the quality score of STRM?

Streamline Health Solutions Inc has a Quality Score of 24/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Streamline Health Solutions Inc (STRM)?

Our model-based price target is the fair value of $0.6700 (as of Sep 13, 2026) from 1 valuation models. Cautious scenario $0.6200, optimistic scenario $0.7300. It is a calculation from audited fundamentals, not an analyst target.

What is the Streamline Health Solutions Inc stock forecast for 2026?

Our models put fair value at $0.6700, about −1% upside versus a price of $0.6800 (fairly valued). Cautious scenario $0.6200, optimistic scenario $0.7300. The calculation is refreshed regularly with new filings.

What is the revenue of Streamline Health Solutions Inc (STRM)?

Streamline Health Solutions Inc reported trailing-twelve-month revenue of about $18.4M (latest available figure, as of Sep 13, 2026).

What is the intrinsic value of Streamline Health Solutions Inc (STRM)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Streamline Health Solutions Inc it is $0.6700 per share (as of Sep 13, 2026), against a price of $0.6800. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).

Is Streamline Health Solutions Inc stock overvalued or undervalued in 2026?

As of Sep 13, 2026, STRM trades above its calculated fair value: price $0.6800, fair value $0.6700, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of STRM?

No. The price is what the market pays today ($0.6800); the fair value is what the company's own numbers justify ($0.6700). For Streamline Health Solutions Inc the two are $0.0100 per share apart. That gap is exactly why we show both numbers side by side.

How much is Streamline Health Solutions Inc worth?

The market values Streamline Health Solutions Inc at about $23.2M (market capitalisation, as of Sep 13, 2026). Per share that is $0.6800; our models calculate a fair value of $0.6700 per share.

What do the bullish and bearish scenarios say about STRM?

Our models span a range for Streamline Health Solutions Inc: cautious scenario $0.6200, base $0.6700, optimistic $0.7300 per share (as of Sep 13, 2026, price $0.6800). The range comes from different growth and margin assumptions, not from analyst opinions.

How solid is the balance sheet of Streamline Health Solutions Inc (STRM)?

Balance-sheet figures for Streamline Health Solutions Inc (as of Sep 13, 2026): return on equity −63.9%, debt of 0.74 per unit of equity. They feed the Quality Score of 24/100, which measures business quality independently of the share price.

How far is STRM from its 52-week high?

Streamline Health Solutions Inc trades at $0.6800, at its 52-week high of $0.6800 and 278% above the low of $0.1800 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.6700 is for.

Which stocks are comparable to Streamline Health Solutions Inc?

From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Streamline Health Solutions Inc stock attractive at the current price?

The data as of Sep 13, 2026: price $0.6800, calculated fair value $0.6700 (−1%), Quality Score 24/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of STRM calculated?

We run Streamline Health Solutions Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.6700, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.5 % above its aggregate fair value. Streamline Health Solutions Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Streamline Health Solutions Inc (STRM)?

The closing price on Oct 2, 2026 was $0.6800. Our model-based fair value is $0.6700, about −1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Streamline Health Solutions Inc right now?

The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Streamline Health Solutions Inc

How large is the market capitalisation of Streamline Health Solutions Inc (STRM)?

The market capitalisation of Streamline Health Solutions Inc is $23.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Streamline Health Solutions Inc (STRM)?

The price-to-sales ratio of Streamline Health Solutions Inc is 1.26 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Streamline Health Solutions Inc (STRM)?

Earnings per share at Streamline Health Solutions Inc are $−2.22. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Streamline Health Solutions Inc (STRM)?

The net margin of Streamline Health Solutions Inc is −56.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Streamline Health Solutions Inc (STRM)?

The return on equity (ROE) of Streamline Health Solutions Inc is −63.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Streamline Health Solutions Inc (STRM)?

On an EBIT basis the return on assets of Streamline Health Solutions Inc is −25.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Streamline Health Solutions Inc (STRM)?

The operating margin of Streamline Health Solutions Inc is −71.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Streamline Health Solutions Inc (STRM)?

Revenue at Streamline Health Solutions Inc is growing −0.7% versus a year earlier (3y avg +1.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Streamline Health Solutions Inc (STRM)?

Earnings per share at Streamline Health Solutions Inc are growing +12.1% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does Streamline Health Solutions Inc (STRM) generate?

The free cash flow of Streamline Health Solutions Inc is −$2.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does Streamline Health Solutions Inc (STRM) carry?

The net debt of Streamline Health Solutions Inc is $10.9M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Streamline Health Solutions Inc in the live analysis

One click puts Streamline Health Solutions Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.